Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial. - Wikidata - wikimedia - TriplyDB

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.

http://www.wikidata.org/entity/Q37457266

about

Novel Pharmacologic Candidates for Treatment of Primary Open-Angle Glaucoma.Initial intraocular pressure reduction by mono- versus multi-therapy in patients with open-angle glaucoma: results from the Glaucoma Intensive Treatment Study

P2860

Q39207696-554A82BB-6F2A-43D8-B7BD-43A7F10C565C Q59137785-4A7E0120-038A-4B5A-B43A-B321A0DA74C4

P2860

Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial.

http://www.wikidata.org/entity/Q37457266

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Ocular hypotensive effect of f ...... : a randomized clinical trial.

@en

Ocular hypotensive effect of f ...... : a randomized clinical trial.

@nl

type

label

Ocular hypotensive effect of f ...... : a randomized clinical trial.

@en

Ocular hypotensive effect of f ...... : a randomized clinical trial.

@nl

prefLabel

Ocular hypotensive effect of f ...... : a randomized clinical trial.

@en

Ocular hypotensive effect of f ...... : a randomized clinical trial.

@nl

P1433

Q37457266-FA558756-C21E-45A8-96AD-915A942C4037

P1476

Q37457266-A9B87749-26EF-4AB9-AE10-D19A07CE9A26

P2093

Q37457266-38EA8141-350A-49DB-A5ED-8BA2640F2899

Q37457266-642F9265-78C0-42F9-84F9-604BD56E0C45

Q37457266-A68A758C-306C-4E55-9B05-F167DFEBE8AB

Q37457266-D0212A3A-5B69-4708-88B0-107E86057321

P2860

Q37457266-1D8D3BCB-6F39-44B4-A3BE-590120E9889F

Q37457266-3D7B3154-4349-440B-960D-54FD6B19DD09

Q37457266-3F3A0E13-D29C-4B2D-92DB-02BFC7D74FB5

Q37457266-4EE38A3C-5A8F-449E-90CE-A6A46C24509A

Q37457266-51CAB559-F391-4A0D-B9AA-AAB66AD08C0B

Q37457266-71A0DE6A-F585-4387-9028-81CBCD73A437

Q37457266-7902F750-29CB-4528-B71F-E34CF1FAC26A

Q37457266-7A55664B-4593-49FB-B0E9-5B72F685F3F2

Q37457266-9A9D7A10-6108-4FBF-BF84-B1C6D9AF770D

Q37457266-A3505F5E-0E55-46C7-A002-A9F53A73BF8E

P2888

Q37457266-911ABE52-C30E-4A2F-88E7-488A6A444DC3

P304

Q37457266-803CB8E7-8502-44B5-88C6-6A185F096245

P31

Q37457266-F47255DD-BDB5-4CEC-A859-AE4CA8C3AD8C

P356

Q37457266-F4D9DAEB-4468-4C6F-9E10-BF1C919DDB94

P433

Q37457266-C97F2A7B-A261-4E33-A004-FC062E729196

P478

Q37457266-A810C35B-DE31-4E2C-90DA-36F24B0EC7D4

P50

Q37457266-D32D9E23-B4C7-4347-82B8-131883B7F3D8

P577

Q37457266-B621FF9F-6B12-4B92-85D4-711607D0423A

P698

Q37457266-D9E1D1A8-A744-46D1-BCC4-8BC741009E6E

P932

Q37457266-0648D8EE-7D30-4F05-BCF0-030EF49B7327

P356

P1433

P1476

Ocular hypotensive effect of f ...... g: a randomized clinical trial

@en

P2093

D A Hubatsch

http://www.w3.org/2001/XMLSchema#string

D L Budenz

http://www.w3.org/2001/XMLSchema#string

H B DuBiner

http://www.w3.org/2001/XMLSchema#string

R D Fechtner

http://www.w3.org/2001/XMLSchema#string

P2860

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension

Two-year treatment patterns and costs in glaucoma patients initiating treatment with prostaglandin analogs.

Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.

Randomized trial of brinzolamide/brimonidine versus brinzolamide plus brimonidine for open-angle glaucoma or ocular hypertension

Addition of a fixed combination of brinzolamide 1%/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension

Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension.

Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%.

Factors associated with lifetime risk of open-angle glaucoma blindness.

P2888

P304

1343-1350

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/EYE.2016.126

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Jonathan S Myers

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27367743

http://www.w3.org/2001/XMLSchema#string

P932

5129854

http://www.w3.org/2001/XMLSchema#string